Revolutionizing the Conventional Surgical Practice
through the Information Revolution
In the age of unprecedented innovation in information technology,
we are bringing cutting-edge technology
in the world of surgery.
We will change conventional wisdom and contribute to dramatic advances in surgery.
We aim to provide safe, high-quality surgery for all.
History
Aiming for “a world
where anyone can receive safe and secure surgery”
Jmees was founded from a meeting between an AI engineer and a surgeon.
They are Hiroki Matsuzaki,an AI engineer who wanted to change the future of medicine
with deep learning and image recognition technology,
and Masaaki Ito and Nobuyoshi Takeshita, surgeons who wanted to change the future of surgery
with innovations at the National Cancer Research Center Hospital East .
While dreaming of “surgical automation” in the distant future,
we continue to develop solutions that will make surgeries more uniform,more efficient, and safer,
with the aim of creating a world where anyone can undergo safe and secure surgery.
2019 Oct.
Estabilishment
2020 Jul.
Certified by the National Cancer Center Venture Accreditation Committee
2020 Nov.
Selected for New Energy Development Organization’s Startup Support Program
2021 Apr.
Hiroki Matsuzaki, CEO, selected for Forbes 30 Under 30 Asia 2021
2022 Mar.
100 million yen in additional Series A funding from MedVenture Partners, Inc.
2021 Nov.
Selected for “Microsoft for Startups,” Microsoft’s startup support program
2022 Apr.
Selected as an innovation promotion project by Japan Agency for Medical Research and Development
2022 Sep.
Won first place worldwide in the image recognition competition at “MICCAI,” the top conference for medical imaging and computer-aided surgery
2023 Nov.
400 million yen in additional Series B funding from MedVenture Partners, Inc.
2024 Aug.
Approval and launch of “SurVis-Hys,” an endoscopic surgical support program, in Japan.
Message
Surgery in Japan is among the highest quality in the world, thanks to the dedication of its surgeons, in addition to its medical facilities and educational system.
However, the number of patients continues to increase while the number of physicians decreases. In addition, minimally invasive surgery, as typified by robotic surgery, has become more common, increasing the technical burden on surgeons. Under these circumstances, the surgical field is constantly exposed to the risk of loss of life and health, and accidents resulting in organ damage during surgery are not going away.
Jmees’ endoscopic support program, SurVis™️, will be a good consultant and partner for surgeons, and we hope to realize that the synergy between surgeons and AI will maximize surgical performance. We aim to remake the common sense of surgery with technology and create a world where all people can undergo safe and secure surgeries.
CEO Hiroki Matsuzaki
Solution
AI-based surgical support system
In conventional surgery, a skilled surgeon’s ability to recognize anatomical structures,
plan the surgical process, and make decisions during the procedure are all tacit knowledge,
so it takes a great deal of experience to master them.
SurVis™︎, an endoscopic surgery support program developed by Jmees,
uses AI to analyze endoscopic surgery images in real time to support the surgeon’s ability to recognize organs,
thereby enabling safer surgery.
Member
Hiroki Matsuzaki
Nobuyoshi Takeshita
Masaaki Ito
Overview
Company Name
CEO
Establishment
Address
Contact
Jmees Inc.
Hiroki Matsuzaki
2019 Oct.
5-4-6 Kashiwanoha, Kashiwa City, Chiba Prefecture,Tokatsu Techno Plaza Room 605
info[at]jmees-inc.com ( change [at] to @ )